NCT02231320View on ClinicalTrials.gov

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2006

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual® Respimat® - inhaler

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02231320 - Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter